Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$380M |
| 2 |
Linde
LIN
|
+$220M |
| 3 |
Dimensional US Marketwide Value ETF
DFUV
|
+$197M |
| 4 |
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
|
+$191M |
| 5 |
VICI Properties
VICI
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$939M |
| 2 |
Microsoft
MSFT
|
+$729M |
| 3 |
AT&T
T
|
+$467M |
| 4 |
CERN
Cerner Corp
CERN
|
+$368M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.07% |
| 2 | Healthcare | 14.01% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.56% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
PAVmed
PAVM
$35.4M
| $141K | ﹤0.01% |
336
-1,085
| -76% | -$524K |
|
4052
Neuronetics
STIM
$138M
| $141K | ﹤0.01% |
43,793
-178,318
| -80% | -$518K |
|
4053
Airgain
AIRG
$73.4M
| $140K | ﹤0.01% |
17,203
| – | – |
|
|
WMC
4054
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $140K | ﹤0.01% |
11,573
-237
| -2% | -$3.21K |
|
4055
Passage Bio
PASG
$14.4M
| $139K | ﹤0.01% |
2,946
-13,170
| -82% | -$615K |
|
4056
TherapeuticsMD
TXMD
$23.5M
| $139K | ﹤0.01% |
13,956
-56,778
| -80% | -$542K |
|
4057
Nu Holdings
NU
$69.2B
| $138K | ﹤0.01% |
+36,847
| New | +$187K |
|
4058
Natural Alternatives International
NAII
$14.4M
| $137K | ﹤0.01% |
13,076
+81
| +0.6% | +$824 |
|
|
OYST
4059
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $136K | ﹤0.01% |
31,393
-73,280
| -70% | -$417K |
|
|
HIMX
4060
Himax Technologies
HIMX
$2.19B
| $135K | ﹤0.01% |
17,987
-22,561
| -56% | -$208K |
|
4061
VirnetX Holding Corp
VHC
$54.4M
| $135K | ﹤0.01% |
5,768
-21,128
| -79% | -$588K |
|
|
LENZ
4062
LENZ Therapeutics
LENZ
$166M
| $134K | ﹤0.01% |
6,938
-28,307
| -80% | -$631K |
|
|
FORA
4063
DELISTED
Forian
FORA
| $133K | ﹤0.01% |
30,269
-132,243
| -81% | -$509K |
|
4064
VOC Energy
VOC
$50.7M
| $133K | ﹤0.01% |
20,467
-324
| -2% | -$2.39K |
|
4065
Rekor Systems
REKR
$85.8M
| $132K | ﹤0.01% |
74,852
-239,062
| -76% | -$682K |
|
|
CLSD
4066
DELISTED
Clearside Biomedical
CLSD
| $131K | ﹤0.01% |
5,931
-523
| -8% | -$12.7K |
|
4067
Nuveen Real Asset Income & Growth Fund
JRI
$356M
| $131K | ﹤0.01% |
+10,000
| New | +$141K |
|
|
OMCC
4068
DELISTED
Old Market Capital Corp
OMCC
| $131K | ﹤0.01% |
14,081
| – | – |
|
|
ZYNE
4069
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $131K | ﹤0.01% |
114,982
-227
| -0.2% | -$289 |
|
|
MILE
4070
DELISTED
Metromile, Inc. Common Stock
MILE
| $131K | ﹤0.01% |
142,549
-785,527
| -85% | -$802K |
|
|
LITS
4071
Lite Strategy Inc
LITS
$32.8M
| $130K | ﹤0.01% |
10,766
-43,942
| -80% | -$478K |
|
4072
Trevi Therapeutics
TRVI
$2.59B
| $130K | ﹤0.01% |
46,298
+34,884
| +306% | +$85.7K |
|
|
ATYR
4073
aTyr Pharma
ATYR
$47.6M
| $130K | ﹤0.01% |
45,871
+1,465
| +3% | +$5.3K |
|
|
VIRX
4074
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $130K | ﹤0.01% |
33,527
-245,099
| -88% | -$698K |
|
|
BMTX
4075
DELISTED
BM Technologies, Inc.
BMTX
| $130K | ﹤0.01% |
22,144
+1,086
| +5% | +$7.6K |
|
Similar funds
Northern Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Northern Trust held 4,878 positions worth $467B, down 18% from $568B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2022 filing shows 136 new, 1,684 increased, 2,550 reduced and 129 closed positions. Its largest new stake was Dimensional US Marketwide Value ETF: 5,908,514 shares worth $187M. The largest sale was Apple, an estimated $939M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 5,908,514 shares worth $187M.
- Northern Trust added most to Warner Bros in Q2 2022, an estimated $380M increase.
- Northern Trust's biggest Q2 2022 reduction was Apple, cutting an estimated $939M.
- Northern Trust fully exited Cerner Corp in Q2 2022, selling an estimated $368M.
- Northern Trust's ten largest holdings make up 21% of its $467B portfolio in Q2 2022.
- Northern Trust opened 136 new positions and closed 129 in Q2 2022.
- Northern Trust's portfolio value fell 18% quarter-over-quarter to $467B.
Based on Northern Trust's 13F filing for Q2 2022, filed 12 Aug 2022.